Safety of combined hypolypidemic therapy in clinical practice
Relevance. Atherogenic dyslipidemia is a key factor in the development of atherosclerotic cardiovascular diseases, which for many years remain the leading cause of mortality worldwide. Cardiovascular mortality can be reduced and prevented by correcting modifiable risk factors, in particular by elimi...
Saved in:
| Main Authors: | A. O. Gukov, V. G. Vinokurov, A. V. Makevnina, S. B. Alieva, Ya. E. Nemstsveridze, А. A. Andrushchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Private institution educational organization of higher education "Medical University "ReaViz"
2025-06-01
|
| Series: | Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье |
| Subjects: | |
| Online Access: | https://vestnik.reaviz.ru/jour/article/view/1194 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE
by: V. A. Korneva, et al.
Published: (2015-09-01) -
Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council
by: M. V. Ezhov, et al.
Published: (2021-03-01) -
Risk factors for cholelithiasis (literature review)
by: B. A. Sakhabetdinov, et al.
Published: (2025-06-01) -
Physiological basis for treatment of diabetic foot syndrome complicated by distal arterial ischemia of the lower extremities using inhalation of a heated oxygen-helium mixture (literature review)
by: V. O. Maslov, et al.
Published: (2025-08-01) -
Study of blood serum morphology and homeostasis of rats against acute hypoxia of different genesis under antihypoxant treatment
by: E. S. Kanaeva, et al.
Published: (2025-04-01)